Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial

被引:0
作者
Hye Rim Na
O Sung Kwon
Joon Kyu Kang
Yong Han Kim
Ju Yong Lim
机构
[1] The Catholic University of Korea Seoul St. Mary’s Hospital,Department of Cardiothoracic Surgery
[2] The Catholic University of Korea Eunpyeong St. Mary’s Hospital,Department of Cardiology
[3] The Catholic University of Korea Eunpyeong St. Mary’s Hospital,Department of Cardiothoracic Surgery
来源
Trials | / 23卷
关键词
PCSK9 inhibitor; Evolocumab; Coronary artery bypass grafting; Ischemia-reperfusion injury; Coronary artery disease; Major adverse cardiovascular events;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 125 条
  • [31] Kaushik A(undefined)undefined undefined undefined undefined-undefined
  • [32] Kapoor A(undefined)undefined undefined undefined undefined-undefined
  • [33] Agarwal SK(undefined)undefined undefined undefined undefined-undefined
  • [34] Pande S(undefined)undefined undefined undefined undefined-undefined
  • [35] Tewari P(undefined)undefined undefined undefined undefined-undefined
  • [36] Majumdar G(undefined)undefined undefined undefined undefined-undefined
  • [37] Mannacio VA(undefined)undefined undefined undefined undefined-undefined
  • [38] Iorio D(undefined)undefined undefined undefined undefined-undefined
  • [39] De Amicis V(undefined)undefined undefined undefined undefined-undefined
  • [40] Di Lello F(undefined)undefined undefined undefined undefined-undefined